Hui Wang

Hui Wang

Auto-generated profile, based on publicly available information

Hui Wang

Department of Orthopaedics(Musculoskeletal Oncology), Clinical oncology School of Fujian Medical University, Fuzhou City, People’s Republic of China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Mediators of Inflammation
Verified
Journal Article
Open access
XLXin Lin
Xin Lin
YXYuan Xia
Yuan Xia
XYXiu Yang
Xiu Yang
PNPeng Niu
Peng Niu
HWHui Wang
Hui Wang
FLFei-Yue Lin
Fei-Yue Lin
Spinal cord injury (SCI) triggers severe neuroinflammation, impeding recovery. While microglial M1 polarization and pyroptosis are key drivers, their upstream regulators are incompletely understood. This study investigated the role of the ubiquitin ligase tripartite motif‐containing protein 14 (TRIM14) in regulating neuroinflammation following SCI. Using rat SCI models and BV2 microglia exposed to lipopolysaccharide (LPS), we assessed TRIM14 expression and its functional impact via knockdown and overexpression, alongside pharmacological neurofilament (NF)‐κB inhibition (pyrrolidine dithiocarbamate [PDTC]). TRIM14 was upregulated in injured spinal cords and microglia, associated with injury severity. TRIM14 knockdown in microglia stabilized IκBα by inhibiting its ubiquitination, thereby suppressing NF‐κB activation, M1 polarization, and NLRP3‐mediated pyroptosis. Conversely, TRIM14 overexpression exacerbated inflammation, effects markedly reversed by PDTC. In SCI rats, intralesional AAV‐CRISPR/CasRx‐mediated TRIM14 silencing significantly attenuated neuroinflammation and neuronal apoptosis, enhanced axonal regeneration, and improved locomotor function. Mechanistically, TRIM14 knockdown suppressed NF‐κB/NLRP3 signaling, promoting a prorepair microenvironment. These results identify TRIM14 as a critical regulator of microglial activation and pyroptosis post‐SCI, suggesting its therapeutic targeting could be a viable strategy to promote neural repair.

31 October 2025 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
HWHui Wang
Hui Wang
PNPeng Niu
Peng Niu
XYXiu Yang
Xiu Yang
XLXin Lin
Xin Lin
GWGuanyin Wu
Guanyin Wu
FLFei-Yue Lin
Fei-Yue Lin
Symptomatic lumbar spondylolysis often disables young athletes. We compared three motion-preserving techniques—modified Scott (MST), pedicle screw system (PSS), and dual-stability construct (DSC)—for pars healing and functional recovery. We retrospectively reviewed 103 active adults (18–40 years) with L3/L4/L5 spondylolysis treated at a single centre between 2017 and 2023. Patients were allocated to modified Scott (MST, n = 33), pedicle-screw (PSS, n = 27) or dual-stability construct (DSC, n = 43). All underwent isthmic debridement, autologous grafting and identical rehabilitation. CT (computed tomography) evaluated pars healing; VAS (Visual Analogue Scale) and JOA-L (Japanese Orthopaedic Association) scores, complications and Magnetic resonance imaging (MRI) Pfirrmann grading were recorded. At 17.5 ± 6.5 months, DSC achieved the highest healing rate (95.3%) versus PSS (88.9%) and MST (60.6%) (P < 0.001). DSC and PSS were independent predictors of healing (Risk ratios (RR) 12.9 and 4.6 vs. MST). JOA improvement was greatest with DSC (80.53%) and PSS (79.89%) versus MST (67.74%). MST exhibited 12% implant failure (spinous cut-through). No adjacent-disc degeneration was observed in PSS or DSC, supporting short-term motion preservation. CT type II/III defects and overweight status predicted non-union. PSS and DSC offer significant advantages over MST for treating symptomatic lumbar spondylolysis in young active adults, with DSC yielding the most favorable outcomes. The dual-stability construct, integrating intra- and intersegmental fixation, enhances pars healing and maintains disc health, supporting its use as a motion-preserving and biomechanically robust technique. These findings may guide surgical decision-making and contribute to improved recovery and functional restoration in athletic youth.

1 February 2026 in Orthopedic Research and Reviews
Verified
Journal Article
Open access
HWHui Wang
Hui Wang
PNPeng Niu
Peng Niu
XYXiu Yang
Xiu Yang
XLXin Lin
Xin Lin
JLJinquan Li
Jinquan Li
FLFei-Yue Lin
Fei-Yue Lin
Spondylolisthesis is a spinal disorder characterized by abnormal vertebral displacement, primarily affecting the lumbar region. Understanding the genetic factors underlying its progression is critical. Patients and Methods: This study aimed to identify key genes influencing spondylolisthesis progression. The summary-data-based Mendelian randomization (SMR) analysis was conducted to evaluate gene expression quantitative trait (eQTL) and DNA methylation QTL (mQTL) data that were causally associated with spondylolisthesis. Subsequently, key genes were discerned by Bayesian colocalization analysis. To validate the findings, Quantitative real time polymerase chain reaction (qRT-PCR) experiments were conducted using human osteosarcoma cells (SW-1353). Additionally, enrichment analysis, small molecule compounds prediction and molecular docking were performed to investigate how the key genes might impact spondylolisthesis. Results: SMR analysis identified 841 cis-eQTLs and 3,224 mQTLs potentially linked to spondylolisthesis (P < 0.05). Bayesian colocalization revealed LOXL4 as a key gene, with posterior probabilities (PPH4) exceeding 0.90 for both eQTL (ENSG00000138131) and mQTL (cg09335911). LOXL4 is implicated in pathways like "protein oxidation" and "collagencontaining extracellular matrix", which are critical for tissue integrity. Molecular docking suggested that LOXL4 binds strongly to estradiol and progesterone, pointing to a potential mechanism of hormonal regulation in spondylolisthesis. However, this remains a hypothesis requiring further experimental validation. Additionally, qRT-PCR experiments in hydrogen peroxide-treated SW1353cells showed that LOXL4 expression changes were consistent with our bioinformatics predictions, although this in vitro model may not fully reflect the gene's role in spondylolisthesis. Conclusion: This findings suggest LOXL4 as a candidate gene involved in spondylolisthesis progression and a potential therapeutic target. Nevertheless, out results are preliminary and further research is needed to confirm LOXL4's role in this condition.

7 May 2026 in Acupuncture & Electro-Therapeutics Research: International Journal of Integrated Medicine
Verified
Journal Article
Closed access
HWHui Wang
Hui Wang
CYChao Yan
Chao Yan
JXJie Xiao
Jie Xiao
GWGuanyin Wu
Guanyin Wu
JHJiyue Huang
Jiyue Huang
XSXiaotang Sun
Xiaotang Sun
Background: Acute lumbar sprain (ALS) is a common cause of acute low back pain. Wrist–ankle acupuncture (WAA) and related regimens are widely used in China for pain relief, but their comparative efficacy remains controversial. Objective: To evaluate the efficacy and safety of WAA and related therapeutic regimens for ALS using network meta-analysis (NMA) and conventional meta-analysis (CMA). Methods: Major English and Chinese databases were searched from inception to August 30, 2025 for randomized controlled trials (RCTs) of adults with ALS treated by WAA-based regimens. An NMA and CMA were conducted. Outcomes included clinical efficacy, pain intensity score, Japanese Orthopedic Association (JOA) score, Oswestry disability index (ODI), lumbar range of motion, inflammatory markers, and occurrence of adverse events. The risk of bias was evaluated using the Cochrane Collaboration criteria, and statistical significance was set at p < 0.05. Results: A total of 14 trials involving 1384 participants were included, with subjects assigned to a WAA-based treatment group (TG) or to a control group (CG) receiving other interventions. Both NMA and CMA showed that WAA and its related regimens alleviated the symptoms and signs of ALS to varying degrees, with a low incidence of adverse events and additional reduction in circulating inflammatory markers. Based on cumulative ranking probabilities, WAA combined with medication (WAACWM) showed a trend toward being the highest-ranked intervention; however, no significant superiority was demonstrated between regimens. Conclusion: WAA and related therapeutic regimens appear effective and safe for ALS. WAACWM may offer the greatest benefit. Further high-quality RCTs with direct comparisons are still needed to confirm these findings.